Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-03-20 @ 7:41 AM
Study NCT ID:
NCT03531918
Status:
COMPLETED
Last Update Posted:
2023-08-30
First Post:
2018-05-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
Sponsor:
Fred Hutchinson Cancer Center
Organization: